These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 2256685)

  • 41. Dapsone-resistant leprosy-the THELEP approach.
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):421-5. PubMed ID: 7042606
    [No Abstract]   [Full Text] [Related]  

  • 42. [Sensitivity to dapsone, sulfamethoxypyridazine and ethionamide of mycobacterium leprae taken from patients treated by the drugs].
    Pattyn SR; Rollier MT; Rollier R; Verdoolaeghe-Van Loo G
    Int J Lepr Other Mycobact Dis; 1975; 43(4):356-63. PubMed ID: 776843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique].
    Constant-Desportes-Relouzat M; Grosset J; Guelpalauras CC; Salvini B; Cales-Quist D
    Acta Leprol; 1986; 4(3):293-300. PubMed ID: 3551468
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevalence of secondary dapsone resistance in Nepal.
    Samuel NM; Samuel S; Loudon J; Neupani K; Adiga RB
    Indian J Lepr; 1984; 56(4):823-7. PubMed ID: 6398344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
    Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
    Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
    Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
    [No Abstract]   [Full Text] [Related]  

  • 47. [Advances in the chemotherapy of leprosy].
    Grosset J
    Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The clinical diagnosis of dapsone resistant leprosy.
    Taylor PM
    Lepr India; 1982 Jan; 54(1):117-22. PubMed ID: 7047897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secondary and primary dapsone resistant leprosy: an analysis of 199 patients from St. Thomas Hospital and leprosy project, Chettupattu, South India.
    Aschhoff M; Raj PP; Lilly L; Srinivasan H
    Indian J Lepr; 1988 Jan; 60(1):34-46. PubMed ID: 3060545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clofazimine in the treatment of dapsone resistant leprosy.
    Taylor PM; Alexander R
    Lepr India; 1976 Oct; 48(4 Suppl):709-12. PubMed ID: 800234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
    Gelber RH; Humphres RC; Fieldsteel AH
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-incident (simultaneous) dapsone sensitive and dapsone resistant leprosy.
    McDougall AC; Ross WF
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):214-5. PubMed ID: 6749709
    [No Abstract]   [Full Text] [Related]  

  • 53. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 54. Dapsone-resistant leprosy.
    Almeida JG; Chacko CJ
    Lepr Rev; 1984 Jun; 55(2):183. PubMed ID: 6379353
    [No Abstract]   [Full Text] [Related]  

  • 55. Multiple relapses in borderline leprosy--a case report.
    Ramachandran A; Seshadri PS
    Indian J Lepr; 1986; 58(4):623-5. PubMed ID: 3553362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug sensitivity of M. leprae isolated from leprosy patients administered DDS for long period of time.
    Murohashi T; Yoshida K
    Acta Leprol; 1978; (73):13-28. PubMed ID: 108909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Six cases of dapsone-resistant tuberculoid leprosy.
    Pearson JM; Kiran KU; Stanley JN
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):534-5. PubMed ID: 6399070
    [No Abstract]   [Full Text] [Related]  

  • 58. The activity of rifabutin against Mycobacterium leprae.
    Yoder LJ; Jacobson RR; Hastings RC
    Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dapsone resistance in leprosy.
    Browne SG
    Trans St Johns Hosp Dermatol Soc; 1973; 59(2):225-9. PubMed ID: 4602407
    [No Abstract]   [Full Text] [Related]  

  • 60. Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compounds.
    Balakrishnan S; Mester L; Venkataramaniah HN; Bhatia VN
    Indian J Lepr; 1985; 57(2):323-8. PubMed ID: 3908578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.